, Tracking Stock Market Picks
Enter Symbol:
Talon Therapeutics Inc (TLON) [hlAlert]

Above Average
down 82.47 %

Hana Biosciences, Inc. (HNAB) rated Above Average by Caris & Company

Posted on: Thursday,  Mar 13, 2008  1:25 PM ET by Caris & Company

Caris & Company rated Above Average Talon Therapeutics Inc (OTCBB: TLON) on 03/13/2008, when the stock price was $0.89.
Since then, Talon Therapeutics Inc has lost 82.47% as of 07/17/2013's recent price of $0.16.
If you would have followed this Caris & Company's recommendation on TLON, you would have lost 82.47% of your investment in 1952 days.

Hana Biosciences, a South San Francisco-based biopharmaceutical company that acquires, develops, and commercializes innovative products to advance cancer care. The company is committed to creating value by building a world-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner of choice, and nurturing a unique company culture.

Caris & Company, an investment bank created by a diverse group of leading Wall Street professionals. We are founded on the basic principle that Wall Street requires a different type of organization: One that offers objective, conflict-free research, acute focus on customer service, broad institutional coverage, and an unwavering commitment to increasing the value of our clients' portfolios. Quite simply, our goal is to generate solid investment ideas for our clients. We offer a unique, differentiated, conflict-free research perspective on large, mid, and small capitalization companies in four growth oriented verticals: Health Care, Technology, Energy, and Consumer.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/13/2008 1:25 PM Buy
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy